News
Nvidia stock continued its slide on Thursday, bringing market cap losses since it disclosed new export controls to nearly ...
US stock futures traded flat on the heels of a bruising day on Wall Street that underscored fears over the economic impact of ...
Nvidia (NVDA) stock fell as much as 4% Thursday, extending the AI chipmaker's nearly 7% decline the prior day after ...
Chagee, a Chinese tea chain, made its U.S. public market debut on the Nasdaq as trade tensions between Washington and Beijing ...
Wall Street strategists still think stocks will recover by the end of 2025 — just not as dramatically as they had once ...
Netflix scored $6.61 EPS ($2.9 billion net income) and $10.54 billion last quarter, besting consensus analyst estimates ...
Webull's shares recently rallied upon their market debut, but the frenzy has driven up the valuation into perilous territory.
There are five major reasons to believe Altria shares can be a safe harbor in nearly any storm. As a nicotine company, Altria ...
Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...
Wall Street on Thursday was mixed, in part due to a post-earnings slump in industry bellwether UNH. Read more here.
12hon MSN
The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of 16 pounds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results